Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 16
Risk Factors and Prediction Nomogram of Cognitive Frailty with Diabetes in the Elderly [Letter]
Received 8 December 2023
Accepted for publication 14 December 2023
Published 18 December 2023 Volume 2023:16 Pages 4143—4144
DOI https://doi.org/10.2147/DMSO.S453933
Checked for plagiarism Yes
Editor who approved publication: Prof. Dr. Muthuswamy Balasubramanyam
Guoling Xu, Yuechou Nong
Department of Endocrinology and Metabolism, The Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, 530021, People’s Republic of China
Correspondence: Yuechou Nong, Email [email protected]
View the original paper by Miss Deng and colleagues
Dear editor
Many clinical risk factors have a bearing on the cognitive dysfunction of the elderly with diabetes mellitus. Recently, Deng et al1 published their research entitled “Risk Factors and Prediction Nomogram of Cognitive Frailty with Diabetes in the Elderly” in Diabetes Metabolic Syndrome and Obesity-Targets and Therapy. Although Suyanto et al2 have provided feedback on this article, further comment should still be helpful for accurate information to the real-world clinical practice. Anyhow, we still want to express our admiration and gratitude for the research work done by the Deng Y team.
The current study delved into the influencing factors of cognitive frailty in elderly patients with diabetes mellitus and developed a nomogram for its assessment.1 The results showed that 27.6% of elderly participants experienced cognitive frailty. Additionally, age, albumin levels, calf circumference, duration of diabetes, intellectual activity, and depressive state were identified as independent risk factors for cognitive frailty in elderly with diabetes mellitus. The training and validation cohorts demonstrated area under curve (AUC) values of 0.866 and 0.821, respectively. They concluded that the nomogram model exhibited good sensitivity and specificity, which provides a reliable tool for assessing the risk of cognitive frailty in old individuals with diabetes mellitus.
We have a few reservations for fully agreeing to the conclusions stated in the article for the following reasons. The reasons are as follows: (1) more evaluation data on the quality of respiratory and sleep, physical activity, and skeletal muscle mass need to be evaluated. Actually, these factors in the elderly are closely associated with cognitive performance;3,4 (2) there is a lack of assessment data on participants’ thyroid function, bone mineral density (BMD), and blood vitamin D levels, which play a crucial role in cognitive frailty in the elderly with diabetes mellitus;5 and (3) the nature defect of cross-sectional studies limits the clinical application of the findings of this study. Therefore, it is necessary to verify the reliability of the predictive model through a longitudinal clinical cohort study. Otherwise, the research results will convey unclear information to clinical practice.
Although this study is only of preliminary nature with futuristic directionality for clinical utility, we still want to congratulate the team on their work.
Disclosure
The authors report no conflicts of interest in this communication.
References
1. Deng Y, Li N, Wang Y, et al. Risk factors and prediction nomogram of cognitive frailty with diabetes in the elderly. Diabetes Metab Syndr Obe. 2023;16:3175–3185. doi:10.2147/DMSO.S426315
2. Suyanto E, Fajar I, Hariyanto T. Risk factors and prediction nomogram of cognitive frailty with diabetes in the elderly. Diabetes Metab Syndr Obe. 2023;2023(16):3899–3900. doi:10.2147/DMSO.S450060
3. Mathieu A, Mazza S, Décary A, et al. Effects of obstructive sleep apnea on cognitive function: a comparison between younger and older OSAS patients. Sleep Med. 2008;9(2):112–120. doi:10.1016/j.sleep.2007.03.014
4. Yao X, Liu B, Hua N, et al. Physical activity mediates the relationship between sarcopenia and cognitive function among older adults in nursing homes. Clin Inter Aging. 2023;2023(18):1863–1871. doi:10.2147/CIA.S425271
5. Gielen E, Dupont J, Dejaeger M, et al. Sarcopenia, osteoporosis and frailty. Metabolism. 2023;145:155638. doi:10.1016/j.metabol.2023.155638
© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.